FDA Import Refusal 799-7678564-3/12/1 — Glaxosmithkline Pharmaceuticals
The FDA refused shipment 799-7678564-3/12/1 from Glaxosmithkline Pharmaceuticals (India) on May 16, 2025. The refused product falls under Drugs and Biologics — ALBENDAZOLE (ANTIPARASITIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 16, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60ZAY02 ALBENDAZOLE (ANTIPARASITIC)
- Charges
- 75